A comprehensive study of progressive cytogenetic alterations in clear cell renal cell carcinoma and a new model for ccRCC tumorigenesis and progression

Advances in Bioinformatics

Volumn 2010, Issue , 2010, Pages

  Zhang, Zhongfa ^a,b   Wondergem, Bill ^a   Dykema, Karl ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78349292982     PISSN: 16878027     EISSN: 16878035     Source Type: Journal    
DOI: 10.1155/2010/428325     Document Type: Article

References (51)

1. Knudson A. G. Jr., Mutation and cancer: statistical study of retinoblastoma Proceedings of the National Academy of Sciences of the United States of America 1971 68 4 820 823
2. Tan M.-H., Rogers C. G., Cooper J. T., Ditlev J. A., Maatman T. J., Yang X., Furge K. A., Teh B. T., Figlin R., Atkins M., Yang J., Gene expression profiling of renal cell carcinoma Clinical Cancer Research 2004 10 18, part 2 6315S 6321S (Pubitemid 39287485)
3. Cohen H. T., McGovern F. J., Renal-cell carcinoma The New England Journal of Medicine 2005 353 23 2477 2490
4. Latif F., Tory K., Gnarra J., Yao M., Duh F.-M., Orcutt M. L., Stackhouse T., Kuzmin I., Modi W., Geil L., Schmidt L., Zhou F., Li H., M. H. W., Chen F., Glenn G., Choyke P., Walther M. M., Weng Y., Identification of the von Hippel-Lindau disease tumor suppressor gene The Science 1993 260 5112 1317 1320 (Pubitemid 23231974)
5. Skinnider B. F., Folpe A. L., Hennigar R. A., Lim S. D., Cohen C., Tamboli P., Young A., De Peralta-Venturina M., Amin M. B., Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors American Journal of Surgical Pathology 2005 29 6 747 754
6. Takahashi M., Yang X. J., Sugimura J., Backdahl J., Tretiakova M., Qian C. N., Gray S. G., Knapp R., Anema J., Kahnoski R., Nicol D., Vogelzang N. J., Furge K. A., Kanayama H., Kagawa S., Teh B. T., Molecular subclassification of kidney tumors and the discovery of new diagnostic markers Oncogene 2003 22 43 6810 6818
7. Cho N. H., Kim S., Ha M. J., Kim H. J., Simultaneous heterogenotypic renal cell carcinoma: immunohistochemical and karyoptic analysis by comparative genomic hybridization Urologia Internationalis 2004 72 4 344 348
8. Junker K., Weirich G., Amin M. B., Moravek P., Hindermann W., Schubert J., Genetic subtyping of renal cell carcinoma by comparative genomic hybridization Recent Results in Cancer Research 2003 162 169 175
9. Kallio J. P., Mahlamki E. H., Helin H., Karhu R., Kellokumpu-Lehtinen P., Tammela T. L. J., Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma Scandinavian Journal of Urology and Nephrology 2004 38 3 225 230
10. Reutzel D., Mende M., Naumann S., Strkel S., Brenner W., Zabel B., Decker J., Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization Cytogenetics and Cell Genetics 2001 93 3-4 221 227
11. Rigola M. A., Casadevall C., Bernus M., Caballn M. R., Fuster C., Gelabert A., Egozcue J., Mir R., Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics Cancer Genetics and Cytogenetics 2002 137 1 49 53
12. Sanjmyatav J., Schubert J., Junker K., Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis Oncology Reports 2005 14 5 1183 1187
13. Broud C., Fournet J.-C., Jeanpierre C., Droz D., Bouvier R., Froger D., Chrtien Y., Marchal J.-M., Weissenbach J., Junien C., Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas Genes Chromosomes and Cancer 1996 17 4 215 224
14. Klatte T., Rao P. N., De Martino M., Larochelle J., Shuch B., Zomorodian N., Said J., Kabbinavar F. F., Belldegrun A. S., Pantuck A. J., Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma Journal of Clinical Oncology 2009 27 5 746 753
15. Gunawan B., Huber W., Holtrup M., Von Heydebreck A., Efferth T., Poustka A., Ringert R.-H., Jakse G., Fzesi L., Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis Cancer Research 2001 61 21 7731 7738
16. Matsuda D., Khoo S. K., Massie A., Iwamura M., Chen J., Petillo D., Wondergem B., Avallone M., Kloostra S. J., Tan M.-H., Koeman J., Zhang Z., Kahnoski R. J., Baba S., Teh B. T., Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC Cancer Letters 2008 272 2 260 267
17. Beroukhim R., Brunet J.-P., Di Napoli A., Mertz K. D., Seeley A., Pires M. M., Linhart D., Worrell R. A., Moch H., Rubin M. A., Sellers W. R., Meyerson M., Linehan W. M., Kaelin W. G. Jr., Signoretti S., Patterns of gene expression and copy-number alterations in von-Hippel Lindau disease-associated and sporadic clear cell carcinoma of the kidney Cancer Research 2009 69 11 4674 4681
18. Jiang F., Desper R., Papadimitriou C. H., Schaffer A. A., Kallioniemi O.-P., Richter J., Schraml P., Sauter G., Mihatsch M. J., Moch H., Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data Cancer Research 2000 60 22 6503 6509
19. Toma M. I., Grosser M., Herr A., Aust D. E., Meye A., Hoefling C., Fuessel S., Wuttig D., Wirth M. P., Baretton G. B., Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array Neoplasia 2008 10 7 634 642
20. Yoshimoto T., Matsuura K., Karnan S., Tagawa H., Nakada C., Tanigawa M., Tsukamoto Y., Uchida T., Kashima K., Akizuki S., Takeuchi I., Sato F., Mimata H., Seto M., Moriyama M., High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma Journal of Pathology 2007 213 4 392 401
21. Nannya Y., Sanada M., Nakazaki K., Hosoya N., Wang L., Hangaishi A., Kurokawa M., Chiba S., Bailey D. K., Kennedy G. C., Ogawa S., A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays Cancer Research 2005 65 14 6071 6079
22. Furge K. A., Dykema K. J., Ho C., Chen X., Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma BMC Genomics 2005 6 1, article 67
23. Presti J. C. Jr., Reuter V. E., Cordon-Cardo C., Mazumdar M., Fair W. R., Jhanwar S. C., Allelic deletions in renal tumors: histopathological correlations Cancer Research 1993 53 23 5780 5783
24. Nagao K., Yamaguchi S., Matsuyama H., Korenaga Y., Hirata H., Yoshihiro S., Fukunaga K., Oba K., Naito K., Allelic loss of 3p25 associated with alterations of 5q22.3 q23.2 may affect the prognosis of conventional renal cell carcinoma Cancer Genetics and Cytogenetics 2005 160 1 43 48
25. Podolski J., Huzarski T., Byrski T., Tooczko A., Wrzecion S., Sikorski A., Mahoy P., Huebner K., Rabbitts P., Lubiski J., Abnormalities of chromosome 5q correlate with morphologic features of better prognosis in clear cell renal carcinomas Polish Journal of Pathology 1995 46 3 163 166
26. Dreijerink K., Braga E., Kuzmin I., Geil L., Duh F.-M., Angeloni D., Zbar B., Lerman M. I., Stanbridge E. J., Minna J. D., Protopopov A., Li J., Kashuba V., Klein G., Zabarovsky E. R., The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7504 7509
27. Kuzmin I., Liu L., Dammann R., Geil L., Stanbridge E. J., Wilczynski S. P., Lerman M. I., Pfeifer G. P., Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection Cancer Research 2003 63 8 1888 1893
28. Velickovic M., Delahunt B., Strkel S., Grebe S. K. G., VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance Cancer Research 2001 61 12 4815 4819
29. Hannula-Jouppi K., Kaminen-Ahola N., Taipale M., Eklund R., Nopola-Hemmi J., Kriinen H., Kere J., The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia PLoS Genetics 2005 1 4, article e50
30. Erler J. T., Bennewith K. L., Nicolau M., Dornhfer N., Kong C., Le Q.-T., Chi J.-T. A., Jeffrey S. S., Giaccia A. J., Lysyl oxidase is essential for hypoxia-induced metastasis Nature 2006 440 7088 1222 1226
31. Wakita T., Hayashi T., Nishioka J., Tamaru H., Akita N., Asanuma K., Kamada H., Gabazza E. C., Ido M., Kawamura J., Suzuki K., Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma International Journal of Cancer 2004 108 4 516 523
32. Miyata Y., Ashida S., Nakamura T., Mochizuki Y., Koga S., Kanetake H., Shuin T., Kanda S., Overexpression of hepatocyte growth factor receptor in renal carcinoma cells indirectly stimulates tumor growth in vivo Biochemical and Biophysical Research Communications 2003 302 4 892 897
33. Chen Y.-T., Tu J. J., Kao J., Zhou X. K., Mazumdar M., Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma Clinical Cancer Research 2005 11 18 6558 6566
34. Young A. N., Salles P. G. D. O., Lim S. D., Cohen C., Petros J. A., Marshall F. F., Neish A. S., Amin M. B., Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays American Journal of Surgical Pathology 2003 27 2 199 205
35. Baldewijns M. M., Thijssen V. L., Van Den Eynden G. G., Van Laere S. J., Bluekens A. M., Roskams T., Van Poppel H., De Brune A. P., Griffioen A. W., Vermeulen P. B., High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile British Journal of Cancer 2007 96 12 1888 1895
36. Yamakawa M., Liu L. X., Belanger A. J., Date T., Kuriyama T., Goldberg M. A., Cheng S. H., Gregory R. J., Jiang C., Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis American Journal of Physiology 2004 287 4 F649 F657
37. Currie M. J., Gunningham S. P., Tumer K., Han C., Scott P. A. E., Robinson B. A., Chong W., Harris A. L., Fox S. B., Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia Journal of Pathology 2002 198 4 502 510
38. Mandriota S. J., Turner K. J., Davies D. R., Murray P. G., Morgan N. V., Sowter H. M., Wykoff C. C., Maher E. R., Harris A. L., Ratcliffe P. J., Maxwell P. H., HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron Cancer Cell 2002 1 5 459 468
39. Nickerson M. L., Warren M. B., Toro J. R., Matrosova V., Glenn G., Turner M. L., Duray P., Merino M., Choyke P., Pavlovich C. P., Sharma N., Walther M., Munroe D., Hill R., Maher E., Greenberg C., Lerman M. I., Linehan W. M., Zbar B., Schmidt L. S., Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub syndrome Cancer Cell 2002 2 2 157 164
40. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S. III, Johnson B. E., Skolnick M. H., A cell cycle regulator potentially involved in genesis of many tumor types The Science 1994 264 5157 436 440
41. Bui M. H. T., Seligson D., Han K.-R., Pantuck A. J., Dorey F. J., Huang Y., Horvath S., Leibovich B. C., Chopra S., Liao S.-Y., Stanbridge E., Lerman M. I., Palotie A., Figlin R. A., Belldegrun A. S., Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy Clinical Cancer Research 2003 9 2 802 811
42. Tang S.-W., Chang W.-H., Su Y.-C., Chen Y.-C., Lai Y.-H., Wu P.-T., Hsu C.-I., Lin W.-C., Lai M.-K., Lin J.-Y., MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells Cancer Letters 2009 273 1 35 43
43. Greenberg J. I., Shields D. J., Barillas S. G., Acevedo L. M., Murphy E., Huang J., Scheppke L., Stockmann C., Johnson R. S., Angle N., Cheresh D. A., A role for VEGF as a negative regulator of pericyte function and vessel maturation Nature 2008 456 7223 809 813
44. Gordan J. D., Lal P., Dondeti V. R., Letrero R., Parekh K. N., Oquendo C. E., Greenberg R. A., Flaherty K. T., Rathmell W. K., Keith B., Simon M. C., Nathanson K. L., HIF- Effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma Cancer Cell 2008 14 6 435 446
45. Sato E., Torigoe T., Hirohashi Y., Kitamura H., Tanaka T., Honma I., Asanuma H., Harada K., Takasu H., Masumori N., Ito N., Hasegawa T., Tsukamoto T., Sato N., Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma Clinical Cancer Research 2008 14 21 6916 6923
46. An J., Rettig M. B., Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity Molecular and Cellular Biology 2005 25 17 7546 7556
47. Clifford S. C., Prowse A. H., Affara N. A., Buys C. H. C. M., Maher E. R., Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis Genes Chromosomes and Cancer 1998 22 3 200 209
48. Banks R. E., Tirukonda P., Taylor C., Hornigold N., Astuti D., Cohen D., Maher E. R., Stanley A. J., Harnden P., Joyce A., Knowles M., Selby P. J., Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer Cancer Research 2006 66 4 2000 2011
49. Rankin E. B., Tomaszewski J. E., Haase V. H., Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor Cancer Research 2006 66 5 2576 2583
50. Ma W., Tessarollo L., Hong S.-B., Baba M., Southon E., Back T. C., Spence S., Lobe C. G., Sharma N., Maher G. W., Pack S., Vortmeyer A. O., Guo C., Zbar B., Schmidt L. S., Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene Cancer Research 2003 63 17 5320 5328
51. Braga E., Senchenko V., Bazov I., Loginov W., Liu J., Ermilova V., Kazubskaya T., Garkavtseva R., Mazurenko N., Kisseljov F., Lerman M. I., Klein G., Kisselev L., Zabarovsky E. R., Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: allelotyping and quantitative real-time PCR International Journal of Cancer 2002 100 5 534 541